Delivery of Immobilized IFN-γ With PCN-333 and Its Effect on Human Mesenchymal Stem Cells

dc.contributor.authorPhipps, Josh
dc.contributor.authorHaseli, Mahsa
dc.contributor.authorPinzon-Herrera, Luis
dc.contributor.authorWilson, Ben
dc.contributor.authorCorbitt, Joshua
dc.contributor.authorServoss, Shannon
dc.contributor.authorAlmodovar, Jorge
dc.date.accessioned2024-03-26T17:35:46Z
dc.date.available2024-03-26T17:35:46Z
dc.date.issued2023-01-04
dc.description.abstractInterferon-gamma (IFN-γ) plays a vital role in modulating the immunosuppressive properties of human mesenchymal stem/stromal cells (hMSCs) used in cell therapies. However, IFN-γ suffers from low bioavailability and degrades in media, creating a challenge when using IFN-γ during the manufacturing of hMSCs. Metal–organic frameworks (MOFs), with their porous interiors, biocompatibility, high loading capacity, and ability to be functionalized for targeting, have become an increasingly suitable platform for protein delivery. In this work, we synthesize the MOF PCN-333(Fe) and show that it can be utilized to immobilize and deliver IFN-γ to the local extracellular environment of hMSCs. In doing so, the cells proliferate and differentiate appropriately with no observed side effects. We demonstrate that PCN-333(Fe) MOFs containing IFN-γ are not cytotoxic to hMSCs, can promote the expression of proteins that play a role in immune response, and are capable of inducing indoleamine 2,3-dioxygenase (IDO) production similar to that of soluble IFN-γ at lower concentrations. Overall, using MOFs to deliver IFN-γ may be leveraged in the future in the manufacturing of therapeutically relevant hMSCs.
dc.description.sponsorshipThis work was financially supported in part by the National Science Foundation under grant no. 2051582 and by the University of Arkansas Cell and Molecular Biology Graduate Program by providing J.P. with a scholarship.The authors thank the Arkansas Nano & Biomaterials Characterization Facility for their assistance with SEM. The authors thank the University of Arkansas Chemistry Department for access to the XRD.
dc.description.urihttps://pubs.acs.org/doi/10.1021/acsbiomaterials.2c01038
dc.format.extent11 pages
dc.genrejournal articles
dc.genrepostprints
dc.identifierdoi:10.13016/m2quyx-p8ak
dc.identifier.citationPhipps, Josh, Mahsa Haseli, Luis Pinzon-Herrera, Ben Wilson, Joshua Corbitt, Shannon Servoss, and Jorge Almodovar. “Delivery of Immobilized IFN-γ With PCN-333 and Its Effect on Human Mesenchymal Stem Cells.” ACS Biomaterials Science & Engineering 9, no. 2 (February 13, 2023): 671–79. https://doi.org/10.1021/acsbiomaterials.2c01038.
dc.identifier.urihttps://doi.org/10.1021/acsbiomaterials.2c01038
dc.identifier.urihttp://hdl.handle.net/11603/32606
dc.publisherACS
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Chemical, Biochemical & Environmental Engineering Department Collection
dc.rightsThis document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Biomaterials Science & Engineering, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acsbiomaterials.2c01038.
dc.titleDelivery of Immobilized IFN-γ With PCN-333 and Its Effect on Human Mesenchymal Stem Cells
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-1151-3878

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
IFN manuscript (Revised and clean) TOC Delivery of Immobilized IFN.pdf
Size:
2.41 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description: